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pilepsy is a disease of the brain and ‘exists in 
a patient who has had a seizure and whose 
brain, for whatever reason, demonstrates a 
pathologic and enduring tendency to have 
recurrent seizures (Fisher et al, 2014 {AQ4: 
Referencing style has been changed throughout. Please 
check that this has been done correctly}). In the UK, 
epilepsy is estimated to affect approximately 400 000 
people, with most cases well controlled with anti-
epileptic drugs (AEDs) (National Institute for Health 
and Care Excellence (NICE), 2018). 
Epilepsy can have a profound impact on a person’s 
quality of  life (QoL) and continues to be stigmatised 
in society, often because of poor understanding by the 
general population (Mula and Sander, 2016). Levels 
of depression and anxiety are high in those living with 
epilepsy, with the psychosocial difficulties that result 
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from living with epilepsy potentially having a greater 
impact than the disease itself  (Mula and Sander, 2016). 
Suicide rates are twice as high in those living with 
epilepsy as in the general population, and three times as 
high {AQ5: Edit OK?} when the disease is accompanied 
by psychiatric co-morbidity (Mula and Sander, 2016). 
The side effects of medications used to manage seizures 
also impact QoL negatively (Fisher et al, 2015).
The negative impact that epilepsy exerts on an 
individual’s QoL is linked with poor mental health, 
poor outcomes and an increased risk of  sudden 
unexpected death in epilepsy (SUDEP) (NICE, 2015). 
Although uncommon, SUDEP is a leading cause of 
premature mortality in epilepsy (Ellis and Szabo, 2018). 
This article examines SUDEP, including risk factors, 
pathophysiology and the role of the nurse in reducing 
risk through improving how people live with epilepsy. 
It aims to present nurses with knowledge that develops 
and clarifies understanding and develops {AQ6: Can 
we replace this second ‘develops’ with ‘improves’?} their 
practise.
What is SUDEP?
SUDEP is defined as ‘sudden, unexpected, witnessed 
or unwitnessed, non-traumatic and non-drowning 
death, in an individual with epilepsy, with or without 
evidence for a seizure and excluding documented status 
epilepticus, in which post mortem does not reveal a 
cause of death’ (Nashef et al, 2012). In addition, a near-
SUDEP event is one in which ‘cardiorespiratory arrest 
was reversed by resuscitation efforts with subsequent 
survival for more than 1 hour that has no structural 
cause’ (Nashef et al, 2012). 
Incidence rates and prevalence 
Neurological-related deaths have increased by 39% 
since 2001, with epilepsy the third-most common cause. 
Since 2014, there has been a 9% increase in epilepsy 
mortality, with a mean age of  death of  70 years; 
epilepsy-related deaths are three times more likely to 
occur in deprived areas, with an occurrence rate of 13 
per 100 000 population (Public Health England, 2018).
Every person with epilepsy is at risk of  SUDEP, 
















which has an estimated incidence rate of 1.16 cases per 
1000 population or 0.81 per 100 000 population {AQ7: 
Please review. The arithmetic does not make sense to 
me?} (Thurman et al, 2014). However, the number 
of  deaths is likely to be an underestimate, as many 
{AQ8: Do you mean that in many cases SUDEP is not 
recorded as the cause of  death?} are not recorded as 
the cause of death (Middleton et al, 2018). This under-
reporting may result from the unwitnessed nature of 
many cases, with a lack of  awareness and knowledge 
by medics and coroners to certify deaths in this way 
(Flannery and Lomke, 2018).
Risk factors
As all individuals with epilepsy are at risk of, but may 
not die from, SUDEP, a greater understanding of the 
associated risk factors is important. This applies to 
the individual and their care networks, but also the 
professionals responsible for the management of their 
epilepsy and overall health. A large number of SUDEP 
risk factors have been proposed, with the most common 
causes being:
 ■ Generalised tonic–clonic seizures (Shankar et al, 
2018)
 ■ Poor seizure management and subsequent high 
seizure frequency (Shankar et al, 2018)
 ■ Poor AED compliance (NICE, 2018; Shankar et al, 
2018)
 ■ AED polypharmacy (Shankar et al, 2018)
 ■ Nocturnal seizures (Shankar et al, 2018; Watkins et 
al, 2018)
 ■ Being in bed during a seizure, particularly if  sleeping 
in the prone position (Shankar et al, 2018; Watkins 
et al, 2018).
Other potential risk factors include: time since 
diagnosis (especially when diagnosed in childhood) 
(Shankar et al, 2018; Watkins et al, 2018) and 
intellectual disability (Watkins et al, 2018).
Key to management of  these risks factors is an 
understanding that the risk profile evolves over time, 
requiring continual dialogue between patient and 
healthcare professionals, using a patient-centred 
approach to identify and mitigate (where possible) 
individual risk (Shankar et al, 2018).
Genetics and SUDEP
Why certain people are at increased risk, but may not 
ultimately die from SUDEP, is unclear {AQ9: Why is it 
odd that a person is at increased risk of something, but 
succumbs to something else?}. Certain gene mutations 
increase the risk (Bagnall, 2017), but similar to other 
aspects of  SUDEP, the lack of  clear confirmation 
{AQ10: Edit OK?} of cause of death has hampered the 
identification of possible genetic factors that contribute 
to an individual’s risk of SUDEP (Bagnall, 2017).
SUDEP does not show familial inheritance; however, 
several candidate genes have been identified that 
increase SUDEP risk. Genome analysis of brain tissue 
from confirmed SUDEP cases has identified genetic 
variants, including genes responsible for regulating 
synaptic signalling and ion channels responsible {AQ11: 
do you mean genes responsible for ion channels which 
affect the cardiac action potential?} for the cardiac 
action potential (Friedman et al, 2018). This provides a 
plausible link between cardiovascular dysfunction and 
SUDEP (Tiron et al, 2015). Of particular importance 
are genes that can lead to long QT syndrome, which can 
result in cardiac arrhythmias and potentially sudden 
death (Tester and Ackerman, 2014. Detailed analysis 
of the genetic factors that impact an individual’s overall 
SUDEP risk is beyond the scope of  this article, but 
these have been reviewed elsewhere (Bagnall et al, 2017).
Identification of genetic risk factors may not permit 
treatment of  the causes of  SUDEP, but awareness 
should permit more effective management of individual 
risk. For example, medications, such as antidepressants, 
antibiotics and anti-psychotics increase the risk of 
sudden death in individuals with long QT syndrome 
(Cubeddu, 2016). Due to the relative rarity of SUDEP 
events, combined with potential under-reporting 
(Middleton et al, 2018), it remains unclear whether 
certain classes of  medication alter an individual’s 
overall risk.
To ensure effective management of  the SUDEP 
risk, further research into potential genetic mutations 
linked to SUDEP is necessary. This requires rapid 
identification of  SUDEP so that post mortem blood 
samples are available for all cases, to allow a full genetic 
screen (Bagnall et al, 2017).
Pathophysiology of SUDEP
The precise mechanisms that underlie SUDEP remain 
elusive, largely due to the highly unpredictable and 
unwitnessed nature of the event. Despite this, a small 
number of  witnessed SUDEP and near-SUDEP 
events, combined with a greater understanding from 
animal studies, suggest that a SUDEP event activates 
an autonomic response that ultimately results in death. 
The possible mechanisms leading to a SUDEP event 
have been broadly categorised into cardiovascular 
causes and respiratory causes, although it is likely that 
any death is multifactorial.
Cardiovascular system
Cardiovascular dysfunction, particularly cardiac 
arrhythmias, occurs during/after seizures. Sinus 
tachycardia is common, but other arrhythmias also 
occur (Velagapudi, 2012). The MORTality in Epilepsy 
Monitoring Unit Study (MORTEMUS), which 
included 11 definite SUDEP cases, showed sudden 
death resulted from respiratory and arousal system 
dysfunction, and bradycardia in postictal periods. Some 
patients with SUDEP had transient tachyarrhythmias, 
but these episodes were always followed by bradycardia 
and asystole (Ryvlin et al, 2013). The link between 
















susceptibility to SUDEP and cardiovascular function 
has been examined and individuals who died from 
SUDEP had a greater degree of autonomic dysfunction 
and a lower heart rate variability while awake Myers et 
al, 2018).
Respiratory system: can seizure-driven 
laryngospasm explain SUDEP?
A plausible mechanism for a SUDEP event is a 
seizure-driven occlusion of  the airways, possibly due 
to laryngospasm. Although a defining characteristic 
of  SUDEP is a lack of  definite cause (Nashef  et al, 
2012), circumstantial evidence for laryngospasm as 
a precipitating factor is provided by post mortem 
examinations. Pulmonary oedema is a common feature, 
occurring in more than half  of  cases (Kennedy et al, 
2015). Respiratory effort against a closed airway, 
as would occur during laryngospasm, can increase 
pulmonary capillary pressures resulting in oedema 
(Ead, 2003).
Support for laryngospasm as a precipitating factor 
for SUDEP is provided by animal models (Nakase et 
al, 2016; Stewart et al, 2017; Budde et al, 2018) and 
clinical case reports (Tavee and Morris, 2008; Lacuey 
et al, 2018). Animal studies show that seizure activity 
causing full airway obstruction results in a sudden 
death, but airway protection prevents death (Nakase 
et al, 2016). Associated with the laryngospasm was 
a severe bradycardia and EEG changes. In contrast, 
central apnoea (no airflow, no respiratory effort) did 
not result in death (Nakase et al, 2016; Stewart et al, 
2017).
Two main theories have been suggested for how 
seizure activity can lead to laryngospasm. Firstly, 
seizure activity activates recurrent laryngeal nerve tracts, 
which leads to laryngospasm and closure of the airway 
(Stewart et al, 2017). An alternative theory proposes 
that the laryngospasm results from inappropriate 
activation of a protective reflex (Budde et al, 2018). A 
common trigger for non-seizure-related laryngospasm 
is gastro-oesophageal reflux disease (GORD), which 
occurs due to oesophageal sphincter weakening and 
acid leaking into the oesophagus (Kavitt and Vaezi, 
2013). A reflex results in laryngospasm to prevent the 
acid from entering the respiratory system (Loughlin et 
al, 1996). Decreased oesophageal pH occurs prior to 
seizure-induced terminal apnoea, while stopping acid 
from {AQ12: Edit to prevent repeated word OK?} 
entering the oesophagus prevented the terminal apnoea, 
despite similar seizure activity (Budde et al, 2018).
SUDEP and GORD have increased incidence at 
night; nocturnal seizures are a major risk factor for 
SUDEP (Shankar et al, 2018; Watkins et al, 2018), while 
GORD patients report an increase in symptomology 
{AQ13: Can symptomology increase? ‘symptoms’?}, 
presumably due to the ease with which acid can enter 
the oesophagus while recumbent (Kavitt and Vaezi, 
2013). In nocturnal GORD, the laryngospasm may 
be resolved by the individual sitting up, allowing acid 
to drain from the oesophagus; in contrast, during 
an unwitnessed seizure-driven laryngospasm, the 
individual remains unconscious, resulting in terminal 
apnoea (Budde et al, 2018).
Clinical cases supporting the implication of  severe 
laryngospasm are now emerging. Tavee and co-workers 
(2008) reported a case of  near SUDEP that was 
preceded by a laryngospasm; importantly, no alterations 
in the patient’s cardiac function were reported. Lacuey 
et al (2018), reported a video-EEG captured seizure that 
resulted in increased inspiratory effort, visible tracheal 
movements and audible inspiratory stridor. This was 
associated with a rapid reduction in oxygen saturations 
and persistent severe hypoxemia.
Potential treatment strategies for 
individuals with SUDEP
Given the unpredictable nature of SUDEP, reducing 
the risk for susceptible individuals is of  paramount 
importance. A recent Cochrane review (Maguire et al, 
2016) identified various strategies that could be used to 
minimise the risk of a SUDEP event, but concluded that 
more research was required to evaluate the effectiveness 
of any intervention. Strategies included:
 ■ Reduction of the overall risk to patients with epilepsy 
through surgery, effective seizure management and 
education
 ■ Detection of  the clinical manifestations of  seizure 
(cardiorespiratory arrest etc.) through either 
observations or via monitoring devices, which 
might ensure the individual receives supportive 
interventions to prevent death
 ■ Reduction of the risk through safety devices such as 
safety pillows which permit airflow
 ■ Pharmacological interventions targeting serotonergic 
(5-HT), adenosine and opioid signalling pathways.
Due to the key role that the neurotransmitters and 
neuromodulators serotonin, adenosine and opioids play 
in the control of respiratory rate (Ackland et al, 2007; 
Pattinson, 2008), the potential impact of  modulation 
of  endogenous levels of  these substances on SUDEP 
risk has been explored. Serotoninergic {AQ14: 
serotonergic?} neurotransmission underpins respiratory 
control, with serotonergic neurons being postulated as 
the central chemoreceptors that stimulate increases in 
breathing rate (Teran et al, 2014). It is therefore plausible 
to speculate that reductions in serotonergic signalling 
could underpin the changes in respiratory effort that are 
a hallmark of SUDEP. Animal studies that modulate 
the extent of  serotonergic transmission demonstrate 
severe apnoea, decreased responses to hypercapnia and 
issues arousing {AQ15: ‘issues with arousal’, or ‘arising 
from’?} from sleep (Hodges et al, 2009). Additionally, 
these animals also demonstrate a reduced seizure 
threshold (Buchanan et al, 2014). Consequently, it was 
postulated that selective serotonin reuptake inhibitors 
















(SSRIs) may prove beneficial to epileptic individuals 
{AQ16: I think ‘people with epilepsy’, or similar, is now 
preferred?}. SSRIs have shown clinical effectiveness in 
the treatment of  a variety of  diseases where altered 
serotonergic signalling has been implicated, such as 
depression (Cipriani et al, 2018). In seizure-susceptible 
mice, the overall level of  respiratory arrest and death 
was reduced by treatment with the SSRI, fluoxetine 
(Tupal and Faingold, 2006). Similar results were found 
in SSRI-treated epileptic patients {AQ17: ‘patients 
with epilepsy’} who demonstrated reduced oxygen 
desaturation, although these benefits were limited 
to patients with partial seizures and did not benefit 
patients with generalised seizures (Bateman et al, 2010). 
This observation questions the applicability of SSRIs to 
reduce SUDEP risk where poorly controlled generalised 
tonic–clonic seizures are a major risk factor (Shankar 
et al, 2018).
Other proposed pharmacotherapies include 
modulation of  adenosine and opioids levels. It has 
been established that seizures can induce release of 
endogenous opioid from brainstem nuclei (Hammers et 
al, 2007). Given the sensitivity of the respiratory system 
to opioids, as highlighted by the major life-threatening 
side effect of respiratory depression (Pattinson, 2008), 
it has been proposed that administration of the opioid 
antagonist naloxone may reverse postictal hypoxemia 
(Rheims et al, 2016).
Reduction of the likelihood of SUDEP 
occurring: nursing responsibilities {AQ18: 
Edit to heading OK?}
While the risk of SUDEP can never fully be eliminated, 
steps can be taken to reduce it, and this process should 
begin when a person is first diagnosed with epilepsy. 
Best practice guidance by NICE in the UK, states that 
information should {AQ19: Edit OK?} be provided 
to all individuals with epilepsy, including their care 
network, regarding SUDEP. General information about 
epilepsy, medications and risk management should be 
provided not only at the time of  their diagnosis, but 
as ongoing provision. Best practise guidance is to 
tailor this information to the patient’s relative risk. 
The definite risk of SUDEP, although small, should be 
addressed (NICE, 2018). 
Failure to address this complex and sensitive issue 
immediately undermines the ability of  patients and 
their care networks to proactively manage their epilepsy 
and mitigate SUDEP risk. Early discussion of SUDEP 
can aid the grieving process of  people who have 
subsequently lost loved ones (Flannery and Lomke, 
2018).
Raising awareness of  SUDEP, by a neurologist 
or nurse specialist, should therefore occur early, in 
accordance with best practise. A SUDEP checklist 
created by Shankar et al (2018) is one possible way to 
facilitate this. The checklist outlines modifiable and non-
modifiable risk factors, and possible interventions, with 
the key focus being on how SUDEP is communicated. 
Implementation of this checklist significantly reduces 
seizure frequency and influences sleeping positions 
in patients with epilepsy, with an overall reduction in 
participant SUDEP risk.
The checklist provides a structured format that 
initiates healthy conversation, identifies individual 
risk, and leads to proactive patient involvement. It 
also provides clinicians with the appropriate language 
to engage in a difficult but necessary conversation—
something that research has identified as a sticking 
point in SUDEP awareness (Keddie et al, 2016). The 
potential impact of  this simple intervention is ample 
justification for it to be {AQ20: Edit OK?} implemented 
more widely.
An optimal pharmacological regimen should be 
established to control seizure frequency and severity 
(Keddie et al, 2016). However, in practice this is difficult 
to achieve in all patients, especially given that treatment 
efficacy decreases with each additional AED (Smith et 
al, 2015b). AED polypharmacy is a known risk factor 
for SUDEP. It is therefore the role of  the physician 
and, increasingly in the UK, the nurse specialist to 
prescribe and review medications (Goodwin et al, 
2011). This should take into account patient preference, 
as this promotes holistic care (Goodwin et al, 2011) and 
increases patient empowerment Higgins et al, 2018). 
To accompany this, education on the importance 
of  medication compliance should be provided—a 
responsibility for all nursing staff. 
Given the links that exist between epilepsy, QoL and 
mental health (Michaelis, 2018), it is the responsibility 
of all nurses to assess the mental health of their patients 
with epilepsy. There is an association between poor 
mental health and poor medication compliance (Welsh 
and Kerley, 2009), which in individuals with epilepsy is 
a substantial risk factor for SUDEP (Brown et al, 2018). 
Early identification and treatment of  poor mental 
health in people with epilepsy would help to prevent 
poor medication compliance, promote better overall 
health and contribute to improving the QoL of  the 
patient (Lu and Elliott, 2012). This would enable them 
to ‘live better’ with epilepsy and, in turn, would help to 
reduce the risk of a SUDEP event (NICE, 2015).
We should not assume that we know how patients 
feel about their condition, or that we know best about 
how to manage it for that individual. Patients should 
be given permission and space to talk, to inform their 
decisions about subsequent treatment. This ranges 
from simple online or community support to formal 
psychological assessment and management (Smith et 
al, 2015a).
Existing guidance states that all epilepsy patients 
should have access to an epilepsy specialist nurse 
(ESN) (NICE, 2018) Access to an ESN allows for the 
provision of  holistic, person-centred care. It provides 
the patient with a direct point of  access to voice 
concerns and continue to proactively manage their 
















condition alongside specialist support. Such access 
helps to underpin all that is mentioned above, as they 
{AQ21: the ESN?} are best placed to refer patients to 
additional services beyond their remit.
Education should be viewed as the underpinning 
component of  managing SUDEP risk. Our 
responsibility as nurses is to educate our patients on 
ways to optimise their everyday health through health 
promotion. Modifiable risk factors associated with 
SUDEP, for instance poor medication compliance, 
seizure frequency, alcohol consumption, mental health 
and sleep should be addressed (Brown et al, 2013). 
Standard epilepsy advice regarding sleep and alcohol 
consumption should continue in line with best practice 
guidelines, given that these factors contribute to 
increased seizure activity and could therefore contribute 
to an increased risk of unexpected death (Smith et al, 
2015a).
Advice and resources should also be provided. 
Charity organisations such as Epilepsy Action (www.
epilepsy.org.uk) and SUDEP Action (www.sudep.
org) provide a way for patients, families and carers to 
educate themselves on the condition and become part 
of a supportive community. This should not replace the 
need for face-to-face conversation or education, but 
should complement ongoing care provision (Keddie et 
al, 2016). 
Primary care and specialist nurses may be best 
placed to provide this education as they have often 
built a trusting rapport with the patients they see 
regularly. Acute care nurses still have the opportunity 
and responsibility to identify some of  these issues if  
previous engagements have failed to do so, ensuring 
that fewer patients ‘slip through the net’. 
This of  course relies on nursing staff  themselves 
being effectively educated in epilepsy and SUDEP. 
There is potential scope here for ESNs to conduct 
ward-based training on the links between these two 
subjects. Enhanced knowledge in nursing staff  may 
increase confidence in addressing some of  the issues 
laid down in this article. This ultimately benefits their 
patients who themselves become better educated and 
potentially empowered to take control of their health 
and reduce their SUDEP risk.
The responsibilities outlined above lead to 
increased patient and care network knowledge and 
understanding, improved mental health, increased 
treatment compliance and subsequently fewer impatient 
admissions (Buelow et al, 2018). In combination, these 
strategies could help to reduce SUDEP risk, due to 
improved epilepsy management, and could be optimised 
through the SUDEP checklist.
While the role of the non-specialised nurse may seem 
limited they do in fact have a vital role to play as part of 
the wider multi-disciplinary team {AQ22: Edit OK?} to 
facilitate care. Research suggests better outcomes when 
nurses are involved in epilepsy management, regardless 
of specialisation (Buelow et al, 2018). 
Conclusions
SUDEP is a major cause of death in individuals with 
epilepsy. There is no current consensus on the underlying 
pathophysiological causes of SUDEP and further pre-
clinical and clinical research is required. Furthermore, 
as there is no definitive method to reduce the SUDEP 
risk, management of  the individual at risk is key. All 
nursing staff, regardless of  specialty, through the use 
of tools such as the SUDEP checklist, can enable this 
management of risk. The skills and attributes required 
to manage SUDEP risk are not specific; adherence 
to the NMC {AQ23: Nursing and Midwifery Code? 
Please supply reference} code should naturally pave the 
way to effective, holistic and person-centred care and 
need only be applied in the context of epilepsy {AQ24: 
Please explain the last bit of this sentence}. Given the 
overall risk and prevalence of SUDEP, expansion of the 
knowledge of epilepsy and SUDEP within the nursing 
profession is a key process through which management 
CPD reflective questions
 ■ Having read the potential mechanisms for SUDEP, 
consider some simple changes in your area of 
practice that could help to reduce a patient’s risk of 
sudden death? Think about how you might 
implement them? 
 ■ Regardless of specialty, look back through the 
nursing responsibilities proposed in this article and 
think about the following two points. Is enough done 
in your ward area to discuss epilepsy, SUDEP and 
the impact on patient quality of life? How could you 
contribute to the conversation? 
 ■ How might you facilitate the development of your 
knowledge, and also that of others, surrounding 
epilepsy and SUDEP to improve your practice?
KEY POINTS
 ■ Sudden unexpected death in epilepsy (SUDEP) is a 
major cause of death in individuals with epilepsy
 ■ SUDEP risk factors include poor seizure control, 
particularly of tonic–clonic seizures, polypharmacy of 
anti-epileptic drugs and nocturnal seizures
 ■ The underlying pathophysiology of SUDEP is poorly 
understood, but is due in part to cardiorespiratory 
dysfunction
 ■ There are no current treatments for SUDEP, although 
early and regular conversations with patients are 
beneficial to ensuring that the overall risk can be 
reduced
















of risk can be achieved.
{AQ25: One of your reviewers has said:
I found this article very informative, easy to read 
and follow, and believe it will be of  interest to many 
readers. The risk of  SUDEP is a very contemporary 
issue, and this article addresses the matter in a way that 
is applicable to both specialist epilepsy teams as well 
as more generic health care teams. I was particularly 
impressed with the excellent use of  very up-to-date 
references and sources of practice-based evidence. 
Some suggestions:
 ■ I would suggest that your reflective question no2 
asks “is enough done by your team” rather than “in 
your ward” to make this inclusive of a wider range of 
health services rather than just hospital ward-based 
services. Nurses working across the whole range of 
health care may come across patients who are facing 
a SUDEP risk.
 ■ You mention the importance of genes that can lead to 
long QT syndrome. I think a very brief  explanation 
of what long QT syndrome is would be helpful.
 ■ You should write EEG out in full. <[electro-
encephalogram? Brian]>
 ■ You again make a reference to wards with regards to 
the receipt of training, and again you are excluding 
community-based teams and services. 
 ■ You write ‘while the role of the non-specialised nurse 
may seem limited…’. I think you mean that the role 
is limited with regards to the delivery of epilepsy care 
and treatment.
With these few alterations made, my opinion is that 
this article will be ready for publication.}
{AQ26: The other of your reviewers has said:
Very interesting, thought-provoking article which 
should be of  interest to all nurses, especially those 
working in neurosciences. Potential modes of  action 
that may lead to SUDEP very relevant and explained 
well, with the addition of potential role of genetics. 
The following are suggestions that may help clarify 
issues for readers: 
 ■ Key Points: 1. Consider rewording as SUDEP is a 
rare cause of  death and the present wording does 
not reflect this. Page 11 you mention risk is small. 
4. ? may result in a reduction rather than can. <[By 
page 11, reviewer means end of first paragraph under 
the heading Reduction of the likelihood of SUDEP 
occurring: nursing responsibilities. I think 4. refers to 
the last of the Key points. Brian]>
 ■ Reflective Questions: 2 - clinical area rather than 
ward as information can be used in all clinical areas 
including primary / residential.
 ■ 3rd paragraph - ? uncontrolled epilepsy or seizures 
rather than just epilepsy as majority of people with 
epilepsy are seizure free so poor mental health etc 
is not applicable to all. Last sentance ? reword as 
present nurses with knowledge ? information / data 
may be more appropriate. Also review use of word 
develop twice. 
 ■ Incidence rates -page 4 2nd paragraph - Review every 
person as not all patients are at risk as those with 
only myoclonic or only absences seizures are not 
known to be at risk (ref  SUDEP.org) - Also consider 
rewarding Risk Factors - As all individuals are at 
risk. <[I think this refers to section Incidence rates 
and prevalence, start of second paragraph. Brian]>
 ■ Risk factors list: 6th - being in bed - consider 
rewording as sleeping at any time - sofa in afternoon 
-SUDEP has occurred. You may wish to consider 
adding in alcohol / substance abuse, depression & 
lack of observation ( being alone).
 ■ A sample of  a section of, or the SUDEP Shanker 
et al checklist, would enhance the article further 
<[Perhaps send us a table for inclusion? Brian]>.}
 ■
. BJNN
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